Clinical Trial Update: Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria [Phase 1]

View source ↗

Summary

Phase I pharmacokinetic study of pazopanib in frail elderly patients (SIOG criteria) was terminated; the trial investigated pazopanib in diverse metastatic soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Metastatic Cancer (Different Solid Tumour Types) | Phase 1 | Status: TERMINATED